COOPER COMPANIES, INC. News
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
see moreCOOPER COMPANIES, INC. Market News
9d
Cooper Companies Reports Significant Revenue Growth in Q2 2026 Amid Strategic Acquisitions
- San Ramon, CA — August 13, 2026 — The Cooper Companies, Inc. (NYSE: COO), a global leader in medical devices, reported robust financial results for the second quarter of fiscal year 2026, alongside strategic initiatives that have influenced its stock performance.
20d
Cooper Companies' Q2 2026 Earnings and Strategic Developments Impact Stock Performance
Cooper Companies reports strong Q2 2026 earnings and strategic initiatives.
28d
Cooper Companies' Strategic Review and Financial Performance Influence Stock Dynamics
Cooper Companies' strategic review and financial performance impact stock dynamics.
19 Jul at 18:17
Cooper Companies' Stock Performance Amid Recent Financial Developments
Analyzing Cooper Companies' stock movements following Q2 2026 results and strategic investments.
12 Jul at 18:15
Cooper Companies' Q2 2026 Performance and Strategic Developments
Cooper Companies reports record Q2 2026 revenue and strategic updates.
07 Jul at 05:04
Cooper Companies' Strategic Moves and Financial Performance Impact Stock Dynamics
Cooper Companies' recent earnings and strategic decisions influence stock performance.
25 May at 04:21
COO: Strong Q1, Board Upgrade, Buyback Momentum Up
CooperCompanies (COO) posted solid fiscal Q1 2026 results, executed meaningful share repurchases and added veteran executive Paul Keel to the board. With $1.024B revenue, improved margins and $873.9M remaining buyback capacity, investor focus shifts to the June 4 Q2 earnings call for confirmation of sustained momentum across CooperVision and CooperSurgical.